0.4(top 50%)
impact factor
6.9K(top 5%)
papers
53.7K(top 5%)
citations
53(top 10%)
h-index
0.5(top 50%)
impact factor
7.3K
all documents
54.5K
doc citations
71(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Diagnostic criteria for Sweet's syndromeCutis1986284
2Skin metastases in cancer patientsCutis1987189
3The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrheaCutis2002142
4Alpha hydroxy acids: procedures for use in clinical practiceCutis1989139
5Common dermatologic disorders in skin of color: a comparative practice surveyCutis2007114
6Efficacy and safety of a new triple-combination agent for the treatment of facial melasmaCutis2003107
7Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsCutis201186
8Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled studyCutis200183
9Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistanceCutis200782
10UV radiation-induced immunosuppression and skin cancerCutis200480
11Silicone gel sheeting in scar therapyCutis199578
12Response to cosmetic disfigurement: patients with vitiligoCutis198775
13Epidemiology and prevention of skin and soft tissue infectionsCutis200475
14The pathophysiology of photoaging of the skinCutis200575
15Acne vulgaris in the United States: a descriptive epidemiologyCutis201075
16Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatmentCutis200474
17Brittle nails: response to daily biotin supplementationCutis199373
18Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disordersCutis199873
19Sweet's syndrome: clinical spectrum and associated conditionsCutis198972
20Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preferenceCutis200271
21Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a reviewCutis200671
22Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled studyCutis200670
23Tattoo removal with the Q-switched ruby laser and the Q-switched Nd:YAGlaser: a comparative studyCutis199569
24Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteriaCutis199469
25Temporary hair removal in patients with hirsutism: a clinical studyCutis199067
26Laser abrasion for cosmetic and medical treatment of facial actinic damageCutis198967
27Hair and scalp disorders in blacksCutis198367
28Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeksCutis200266
29Alternative therapies commonly used within a population of patients with psoriasisCutis199665
30Pyogenic granulomaCutis200465
31Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitisCutis200464
32Report of an association between discoid lupus erythematosus and smokingCutis199963
33Efficacy and safety of treatment modalities for psoriasisCutis199862
34Skin manifestations of leukemias and lymphomasCutis197861
35Efficacy and safety of topical azelaic acid (20 percent cream): an overview of results from European clinical trials and experimental reportsCutis199661
36Topical niacinamide and barrier enhancementCutis200261
37Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosaceaCutis200561
38Nail psoriasisCutis199260
39Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled studyCutis199960
40Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acneCutis199559
41Cutaneous dental sinus tract, a common misdiagnosis: a case report and review of the literatureCutis200258
42Treatment of pyoderma gangrenosum with methotrexateCutis199657
43Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasmaCutis200557
44Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trialCutis201057
45Safety and efficacy of a new extended-release formulation of minocyclineCutis200656
46Minocycline hyperpigmentation: skin, tooth, nail, and bone involvementCutis198455
47The interaction between acne vulgaris and the psycheCutis200255
48The pathophysiology of acneCutis200555
49Dermatologic changes after systemic cancer therapyCutis198154
50Reactive perforating collagenosis of diabetes mellitus and renal failureCutis198354